Schonfeld Strategic Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 24,460 shares of MDGL stock, worth $4.98 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

24,460

Holding current value

$4.98 Million

% of portfolio

0.05%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$193.33 - $291.99 $4.73 Million - $7.14 Million	24,460 New	24,460 $6.85 Million
Q4 2023 Feb 14, 2024	SELL	$120.4 - $237.13 $7.11 Million - $14 Million	-59,077 Reduced 82.58%	12,458 $2.88 Million
Q3 2023 Nov 14, 2023	BUY	$146.04 - $225.78 $7.55 Million - $11.7 Million	51,670 Added 260.11%	71,535 $10.4 Million
Q2 2023 Aug 14, 2023	SELL	$203.88 - $312.0 $2.03 Million - $3.1 Million	-9,939 Reduced 33.35%	19,865 $4.59 Million
Q1 2023 May 15, 2023	BUY	$231.06 - $307.08 $3.51 Million - $4.67 Million	15,204 Added 104.14%	29,804 $7.22 Million
Q4 2022 Feb 14, 2023	SELL	$58.39 - $296.54 $3.16 Million - $16.1 Million	-54,136 Reduced 78.76%	14,600 $4.24 Million
Q3 2022 Nov 14, 2022	BUY	$60.57 - $79.51 $3.42 Million - $4.48 Million	56,389 Added 456.7%	68,736 $4.47 Million
Q2 2022 Aug 15, 2022	BUY	$58.04 - $100.2 $716,619 - $1.24 Million	12,347 New	12,347 $884,000
Q1 2022 May 16, 2022	SELL	$55.89 - $101.89 $497,700 - $907,330	-8,905 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.34 - $95.09 $224,615 - $295,254	3,105 Added 53.53%	8,905 $754,000
Q3 2021 Nov 16, 2021	SELL	$78.35 - $105.02 $31,339 - $42,008	-400 Reduced 6.45%	5,800 $463,000
Q2 2021 Aug 16, 2021	SELL	$97.2 - $137.59 $2.36 Million - $3.34 Million	-24,254 Reduced 79.64%	6,200 $604,000
Q1 2021 May 17, 2021	BUY	$108.54 - $125.2 $3.31 Million - $3.81 Million	30,454 New	30,454 $3.56 Million
Q4 2020 Feb 16, 2021	SELL	$110.06 - $133.7 $716,160 - $869,985	-6,507 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$99.78 - $124.21 $137,496 - $171,161	-1,378 Reduced 17.48%	6,507 $1,000
Q2 2020 Aug 14, 2020	SELL	$60.13 - $125.71 $2,164 - $4,525	-36 Reduced 0.45%	7,885 $893,000
Q1 2020 May 15, 2020	BUY	$66.76 - $93.49 $528,805 - $740,534	7,921 New	7,921 $529,000
Q2 2019 Aug 14, 2019	SELL	$91.13 - $142.5 $246,051 - $384,750	-2,700 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$103.48 - $143.84 $2.92 Million - $4.06 Million	-28,200 Reduced 91.26%	2,700 $338,000
Q4 2018 Feb 14, 2019	SELL	$94.77 - $215.54 $2.75 Million - $6.25 Million	-29,000 Reduced 48.41%	30,900 $3.48 Million
Q3 2018 Nov 14, 2018	BUY	$207.3 - $300.31 $11.2 Million - $16.2 Million	54,000 Added 915.25%	59,900 $12.8 Million
Q2 2018 Aug 14, 2018	BUY	$101.55 - $313.9 $214,067 - $661,701	2,108 Added 55.59%	5,900 $1.65 Million
Q1 2018 May 15, 2018	BUY	$93.35 - $149.04 $353,983 - $565,159	3,792 New	3,792 $443,000

Others Institutions Holding MDGL

# of Institutions

298

Shares Held

22M

Call Options Held

757K

Put Options Held

370K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $3.48B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Madrigal Pharmaceuticals, Inc. Transaction History